[The effectiveness ot thyroid-hormone therapy following goiter-resection].
The effectiveness of a postoperative thyroid-hormone therapy in preventing a goiter-recidiv was investigated two years after goiter-resection.  Of 3381 patients with goiter, who were operated on in the years 1964 to 1973 in the Surgical Department of the Krankenhaus Nordwest in Frankfurt/Main, Germany, 129 patients who were operated on in the first six months of 1969, were questioned and examined in a follow-up study.  A rezidiv-goiter was found in 4, 6 p.c. of patients.  If only palpable recidiv-goiters are taken into consideration 2, 3 p.c.), patients without postoperative thyroid-hormone therapy developed a recidiv goiter twice as often as patients with thyroid-hormone therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006042:Goiter / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010173:Palpation; D011182:Postoperative Care; D011877:Radionuclide Imaging; D012008:Recurrence; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000627:therapeutic use*; D013965:Thyroidectomy; D013974:Thyroxine / Q000008:administration & dosage / Q000097:blood; D014284:Triiodothyronine / Q000008:administration & dosage / Q000097:blood
D013963:Thyroid Hormones; D014284:Triiodothyronine; D013974:Thyroxine
Die Wirkung einer Rezidivprophylaxe nach Strumaresektion